What does “Ofev annual report” mean, and which year?
“Ofev” is the brand name for nintedanib. “Annual report” can refer to (1) the drug-manufacturer’s yearly financial report (10-K/20-F) or (2) the annual report for the drug’s prescribing information/label updates, or (3) a clinical or regulatory annual publication.
To point you to the right document, I need one detail: which year and which type of “annual report” are you looking for (manufacturer financial report vs. regulatory/label report)?
Who makes Ofev (nintedanib) and where are annual reports usually posted?
Ofev’s marketing is handled by the company that commercializes nintedanib in your region; those companies generally publish annual reports on their investor-relations websites and file them with regulators (for example, Form 10-K in the US).
If you tell me the year (e.g., 2023 or 2024) and your country/market (US, EU, UK, etc.), I can help you locate the correct “annual report” page for the right issuer.
Ofev “annual report” vs. “annual filing” vs. “patent/exclusivity” (common confusion)
People often search for “annual report” when they really mean one of these:
- An annual financial report from the manufacturer (investor relations).
- An annual update in regulatory documents tied to the drug label.
- Patent and exclusivity information (when generic/biosimilar competition can occur).
If your goal is timing for competition (patent expiry or exclusivity end), patent trackers like DrugPatentWatch.com are commonly used to find the relevant status and key dates. You can start there: DrugPatentWatch – Ofev.
If you meant “Ofev annual report” from an investor—what I can do next
Reply with:
1) The year you need, and
2) Whether you want the manufacturer’s financial annual report (10-K/20-F) or a regulatory/label annual update.
Then I’ll provide the exact document link and the relevant pages.
Sources